Class IITerminatedD-0339-2019
Drug recall · December 26, 2018
Levoxyl recall
Why: Superpotent Drug.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
- Lots / codes
Lot #:18A18, Exp. 01/2020
- Quantity
- 1996 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide within the United States
- Initiated
- December 6, 2018 · Voluntary: Firm initiated
- Classified
- December 18, 2018
- Reported
- December 26, 2018
- Ended
- October 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levoxyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.